[
  {
    "ts": "2025-11-25T11:30:00+00:00",
    "headline": "Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment",
    "summary": "The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.",
    "url": "https://www.thedailyupside.com/industries/healthcare/bayer-resurrects-scrapped-blood-thinning-drug-as-breakthrough-stroke-treatment/",
    "source": "The Daily Upside",
    "provider": "yfinance",
    "raw": {
      "id": "96d76b9f-aa4b-32bc-9911-9f2034cf7070",
      "content": {
        "id": "96d76b9f-aa4b-32bc-9911-9f2034cf7070",
        "contentType": "STORY",
        "title": "Bayer Resurrects Scrapped Blood-Thinning Drug as Breakthrough Stroke Treatment",
        "description": "",
        "summary": "The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.",
        "pubDate": "2025-11-25T11:30:00Z",
        "displayTime": "2025-11-25T11:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_daily_upside_435/6a39d535f2e4ef9e6c7effc2d30340df",
          "originalWidth": 1600,
          "originalHeight": 901,
          "caption": "Photo of a Bayer AG office building.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oL0ICHfGKa95jbg4R1O0yQ--~B/aD05MDE7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_daily_upside_435/6a39d535f2e4ef9e6c7effc2d30340df.cf.webp",
              "width": 1600,
              "height": 901,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6BKm02o65HZcR_4Zo4I8lQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_daily_upside_435/6a39d535f2e4ef9e6c7effc2d30340df.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Daily Upside",
          "url": "http://thedailyupside.com/"
        },
        "canonicalUrl": {
          "url": "https://www.thedailyupside.com/industries/healthcare/bayer-resurrects-scrapped-blood-thinning-drug-as-breakthrough-stroke-treatment/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bayer-resurrects-scrapped-blood-thinning-113000634.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T20:14:42+00:00",
    "headline": "A Fresh Look at Bristol-Myers Squibb (BMY) Valuation After Recent Share Price Rebound",
    "summary": "Bristol-Myers Squibb (BMY) shares have seen mixed movement over the past month, with the stock rebounding nearly 9% but still trading below this year’s highs. Investors continue to monitor the company’s performance trends and financials. See our latest analysis for Bristol-Myers Squibb. Even after this month’s strong 8.9% share price return, Bristol-Myers Squibb is still trying to regain its footing following a tough year for total shareholders, who are down nearly 15%. While short-term...",
    "url": "https://finance.yahoo.com/news/fresh-look-bristol-myers-squibb-201442405.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "63b2a8f3-4d4d-3362-b0b8-77a8ce2e89c4",
      "content": {
        "id": "63b2a8f3-4d4d-3362-b0b8-77a8ce2e89c4",
        "contentType": "STORY",
        "title": "A Fresh Look at Bristol-Myers Squibb (BMY) Valuation After Recent Share Price Rebound",
        "description": "",
        "summary": "Bristol-Myers Squibb (BMY) shares have seen mixed movement over the past month, with the stock rebounding nearly 9% but still trading below this year’s highs. Investors continue to monitor the company’s performance trends and financials. See our latest analysis for Bristol-Myers Squibb. Even after this month’s strong 8.9% share price return, Bristol-Myers Squibb is still trying to regain its footing following a tough year for total shareholders, who are down nearly 15%. While short-term...",
        "pubDate": "2025-11-25T20:14:42Z",
        "displayTime": "2025-11-25T20:14:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/isv7n73YBii.eJbbdO3fww--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MRv2ZxXw0SbLt6U2idf4TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5a13d347387951add3c978a1a10a0331.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fresh-look-bristol-myers-squibb-201442405.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fresh-look-bristol-myers-squibb-201442405.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-25T19:01:00+00:00",
    "headline": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi",
    "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
    "url": "https://finance.yahoo.com/news/bmy-wins-ec-nod-label-190100239.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "27a7ca5f-cfbc-373f-8ac9-e2223f6fdae7",
      "content": {
        "id": "27a7ca5f-cfbc-373f-8ac9-e2223f6fdae7",
        "contentType": "STORY",
        "title": "BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi",
        "description": "",
        "summary": "Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.",
        "pubDate": "2025-11-25T19:01:00Z",
        "displayTime": "2025-11-25T19:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmy-wins-ec-nod-label-190100239.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmy-wins-ec-nod-label-190100239.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BAYRY"
            },
            {
              "symbol": "BAYZF"
            },
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]